**Core Concept**
The question is testing the student's knowledge of antithrombotic agents, which are medications that prevent the formation of blood clots. This is a critical concept in the management of thrombotic disorders, such as deep vein thrombosis and pulmonary embolism.

**Why the Correct Answer is Right**
The correct answer is a medication that inhibits the clotting cascade by blocking the action of factor Xa, a key enzyme in the coagulation pathway. This class of medications, known as direct factor Xa inhibitors, works by binding to the active site of factor Xa and preventing it from catalyzing the conversion of prothrombin to thrombin. By inhibiting this step, the formation of blood clots is significantly reduced.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it refers to a medication that actually promotes blood clotting, rather than preventing it. Medications that activate the clotting cascade, such as thrombin, are not antithrombotic.
**Option B:** This option is incorrect because it refers to a medication that is used to treat bleeding disorders, rather than preventing blood clots. Antifibrinolytics, such as aminocaproic acid, work by inhibiting the breakdown of blood clots, rather than preventing their formation.
**Option C:** This option is incorrect because it refers to a medication that is used to treat hypertension, rather than preventing blood clots. Beta blockers, such as propranolol, work by reducing blood pressure through mechanisms unrelated to antithrombotic activity.

**Clinical Pearl / High-Yield Fact**
Direct factor Xa inhibitors, such as rivaroxaban and apixaban, have become a mainstay in the treatment of thrombotic disorders due to their ease of use and reduced risk of bleeding compared to traditional anticoagulants.

**Correct Answer:** D